Literature DB >> 19731638

KIR genes and their role in spondyloarthropathies.

Roberto Díaz-Peña1, Miguel Angel Blanco-Gelaz, Carlos López-Larrea.   

Abstract

Cellular activity of natural killer cells (NK cells) is defined by the balance between activating and inhibitory signals coming from their receptors. With respect to this response, killer immunoglobulin-like receptors (KIR) are unique because of their diversity and capacity to recognize specific human leukocyte antigen (HLA) class I allotypes. Up to the present few studies have experimentally been developed concerning the role of KIR genes in spondyloarthropathies (SpA) and its clear relationship with HLA-B27. However, the role of the HLA-B27 heavy chain homodimers and their possible recognition by KIR receptors in the pathogenesis of spondylarthritides has been studied. Moreover, it has been suggested that NK cells and their receptors could play a role in ankylosing spondylitis (AS) development. Several association studies based on a model in which KIRs synergize with HLAs have also been published. This interaction may generate compound genotypes which provide different levels of activation or inhibition. Furthermore, some of these have been associated with certain SpA, such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731638     DOI: 10.1007/978-1-4419-0298-6_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

Review 1.  Uveitis in seronegative arthritis.

Authors:  Daniel Wendling
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

2.  Contribution of functional KIR3DL1 to ankylosing spondylitis.

Authors:  Ivan V Zvyagin; Ilgar Z Mamedov; Olga V Britanova; Dmitriy B Staroverov; Evgeni L Nasonov; Anna G Bochkova; Anna V Chkalina; Alexei A Kotlobay; Dmitriy O Korostin; Denis V Rebrikov; Sergey Lukyanov; Yuri B Lebedev; Dmitriy M Chudakov
Journal:  Cell Mol Immunol       Date:  2010-09-06       Impact factor: 11.530

3.  Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis.

Authors:  R Díaz-Peña; J R Vidal-Castiñeira; J Mulero; A Sánchez; R Queiro; C López-Larrea
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

4.  Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.

Authors:  María V Martínez-Sánchez; Adela Periago; Isabel Legaz; Lourdes Gimeno; Anna Mrowiec; Natividad R Montes-Barqueros; José A Campillo; José M Bolarin; María V Bernardo; María R López-Álvarez; Consuelo González; María C García-Garay; Manuel Muro; Valentin Cabañas-Perianes; Jose L Fuster; Ana M García-Alonso; José M Moraleda; María R Álvarez-Lopez; Alfredo Minguela
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

5.  Natural killer cells in patients with severe chronic fatigue syndrome.

Authors:  E W Brenu; S L Hardcastle; G M Atkinson; M L van Driel; S Kreijkamp-Kaspers; K J Ashton; D R Staines; S M Marshall-Gradisnik
Journal:  Auto Immun Highlights       Date:  2013-04-16

6.  Genetic Variants in KIR/HLA-C Genes Are Associated With the Susceptibility to HCV Infection in a High-Risk Chinese Population.

Authors:  Chao Shen; Zhijun Ge; Chen Dong; Chunhui Wang; Jianguo Shao; Weihua Cai; Peng Huang; Haozhi Fan; Jun Li; Yun Zhang; Ming Yue
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

7.  Role of KIR3DS1 in human diseases.

Authors:  Christian Körner; Marcus Altfeld
Journal:  Front Immunol       Date:  2012-11-01       Impact factor: 7.561

8.  Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.

Authors:  Achim K Moesta; Peter Parham
Journal:  Front Immunol       Date:  2012-11-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.